New-Onset Diabetes in Covid-19
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
Chee, Y. J., Ng, S. J. H., & Yeoh, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108166 · Cited by 287
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Ren, H., Yang, Y., Wang, F., Yan, Y., Shi, X., Dong, K., Yu, X., & Zhang, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01035-2 · Cited by 200
Cited by
Items 201–300 of 808
Factors Associated With Hospitalization in Children and Adolescents With SARS-CoV-2 Infection
Chao, J. Y., Sugarman, A., Kimura, A., Flamer, S. Z., Jing, T. T., Fernandes, D. M., Khine, H., Shinnar, S., Lo, Y., & Cabana, M. D. (2021) · Clinical Pediatrics · doi:10.1177/00099228211059883 · Cited by 30
Zhang, J. Y., Shang, T., Ahn, D. T., Chen, K. Y., Coté, G. L., Espinoza, J., Mendez, C. E., Spanakis, E. K., Thompson, B., Wallia, A., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820978399 · Cited by 33
Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes
Jia, X., Gesualdo, P., Rasmussen, C. G., Alkanani, A. K., He, L., Dong, F., Rewers, M., Michels, A. W., & Yu, L. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0609 · Cited by 30
Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
Misra, A., Ghosh, A., & Gupta, R. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.01.018 · Cited by 31
Not so sweet and simple: impacts of SARS-CoV-2 on the β cell
Ibrahim, S., Monaco, G. S. F., & Sims, E. K. (2021) · Islets · doi:10.1080/19382014.2021.1909970 · Cited by 32
Post-COVID syndrome: prevalence, organ pathogenesis and routes of correction. A systematic review
Канорский, С. Г. (2021) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2021-28-6-90-116 · Cited by 34
Pawar, A. T., Russo, M., Rani, I., Goswami, K., Russo, G. L., & Pal, A. (2022) · Phytotherapy Research · doi:10.1002/ptr.7461 · Cited by 30
Leitzke, M. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00104-7 · Cited by 29
Mounting clues suggest the coronavirus might trigger diabetes
Mallapaty, S. (2020) · Nature · doi:10.1038/d41586-020-01891-8 · Cited by 30
Priyambada, L., Wolfsdorf, J. I., Brink, S. J., Fritsch, M., Ethel Codner, D., Donaghue, K. C., & Craig, M. E. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13118 · Cited by 33
Post Acute Coronavirus (COVID-19) Syndrome
Chippa, V. M., Aleem, A., & Anjum, F. (2021) · Europe PMC (PubMed Central) · Cited by 68
Charoenngam, N., Alexanian, S. M., Apovian, C. M., & Holick, M. F. (2021) · Nutrients · doi:10.3390/nu13072199 · Cited by 29
Interstitial Lung Fibrosis Following COVID-19 Pneumonia
Lazăr, M., Barbu, E. C., Chițu, C. E., Tilişcan, C., Stratan, L. M., Aramă, Ș. S., Aramă, V., & Ion, D. A. (2022) · Diagnostics · doi:10.3390/diagnostics12082028 · Cited by 35
Cross-Talk of NADPH Oxidases and Inflammation in Obesity
Morawietz, H., Brendel, H., Diaba‐Nuhoho, P., Catar, R. A., Perakakis, N., Wolfrum, C., & Bornstein, S. R. (2023) · Antioxidants · doi:10.3390/antiox12081589 · Cited by 30
Self-citationThe Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Golzardi, M., Hromić‐Jahjefendić, A., Šutković, J., Aydın, O., Ünal‐Aydın, P., Bećirević, T., Redwan, E. M. M. M., Rubio‐Casillas, A., & Uversky, V. N. (2024) · Biomedicines · doi:10.3390/biomedicines12040913 · Cited by 37
The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
Huizinga, G. P., Singer, B. H., & Singer, K. (2020) · Endocrinology · doi:10.1210/endocr/bqaa154 · Cited by 30
Barh, D., Tiwari, S., Andrade, B. S., Weener, M. E., Goés‐Neto, A., Azevedo, V., Ghosh, P., Blum, K., & Ganguly, N. K. (2021) · Molecular Omics · doi:10.1039/d0mo00189a · Cited by 30
Cardiovascular Injury Due to SARS-CoV-2
Bugert, C. L., Kwiat, V. R., Valera, I., Bugert, J. J., & Parvatiyar, M. S. (2021) · Current Clinical Microbiology Reports · doi:10.1007/s40588-021-00160-0 · Cited by 30
Valabhji, J., Barron, E., Bradley, D., Bakhai, C., Khunti, K., & Jebb, S. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00218-7 · Cited by 28
Self-citationLong COVID: Long-Term Impact of SARS-CoV2
Makhluf, H. A., Madany, H., & Kim, K. (2024) · Diagnostics · doi:10.3390/diagnostics14070711 · Cited by 30
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Debuysschere, C., Nekoua, M. P., Alidjinou, E. K., & Hober, D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01004-9 · Cited by 32
Basatemür, E., Jones, A., Peters, M. J., & Ramnarayan, P. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320471 · Cited by 27
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 29
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study
Smati, S., Tramunt, B., Wargny, M., Gourdy, P., Hadjadj, S., & Cariou, B. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01452-5 · Cited by 32
Dravid, A. N., Kashiva, R., Khan, Z. A., Bande, B. D., Memon, D., Kodre, A., Potdar, P., Mane, M., Tamboli, A., Pawar, V., et al. (2022) · Mycoses · doi:10.1111/myc.13435 · Cited by 31
SARS-CoV-2 infection and its effects on the endocrine system
Steenblock, C., Toepfner, N., Beuschlein, F., Perakakis, N., Anjana, R. M., Mohan, V., Mahapatra, N. R., & Bornstein, S. R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101761 · Cited by 27
Self-citationFunding and COVID-19 research priorities - are the research needs for Africa being met?
Antonio, E. S., Alobo, M., Tufet, M., Marsh, K., & Norton, A. (2020) · AAS Open Research · doi:10.12688/aasopenres.13162.1 · Cited by 26
Cariou, B., Pichelin, M., Goronflot, T., Gonfroy‐Leymarie, C., Marre, M., Raffaitin‐Cardin, C., Thivolet, C. H., Wargny, M., Hadjadj, S., & Gourdy, P. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108695 · Cited by 26
SARS-CoV-2 in diabetic pregnancies: a systematic scoping review
Eberle, C., James-Todd, T. M., & Stichling, S. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03975-3 · Cited by 27
SARS-CoV-2 Infection and Pancreatic β Cell Failure
Mine, K., Nagafuchi, S., Mori, H., Takahashi, H., & Anzai, K. (2021) · Biology · doi:10.3390/biology11010022 · Cited by 36
Zhang, J., Shu, T., Zhu, R., Yang, F., Zhang, B., & Lai, X. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113094 · Cited by 29
Kalyanaraman, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101721 · Cited by 28
Morse, J. L., Gay, W., Korwek, K. M., McLean, L. E., Poland, R. E., Guy, J. S., Sands, K., & Perlin, J. B. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.291 · Cited by 26
Srivastava, A., Greenberg, C. R., Sareen, N., Lionetti, V., & Dhingra, S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04396-2 · Cited by 28
Tomulić, K. L., Matko, L., Verbić, A., Milardović, A., Severinski, S., Kolić, I., Dekanić, K. B., Šerifi, S., & Ahel, I. B. (2022) · Medicina · doi:10.3390/medicina58050638 · Cited by 30
The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
Bauer, W., Gyenesei, A., & Kretowski, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147493 · Cited by 30
Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes
Shao, S., Yang, Q., Pan, R., Yu, X., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731974 · Cited by 29
New‐onset diabetes in “long COVID ”
Sathish, T., Anton, M. C., & Sivakumar, T. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13187 · Cited by 24
The interface of COVID-19, diabetes, and depression
Steenblock, C., Schwarz, P. E. H., Perakakis, N., Brajshori, N., Beqiri, P., & Bornstein, S. R. (2022) · Discover Mental Health · doi:10.1007/s44192-022-00007-0 · Cited by 27
Self-citationArghittu, A., Deiana, G., Castiglia, E., Pacifico, A., Brizzi, P., Cossu, A., Castiglia, P., & Dettori, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811212 · Cited by 24
Viruses and Endocrine Diseases
Nekoua, M. P., Debuysschere, C., Vergez, I., Morvan, C., Mbani, C. J., Sané, F., Alidjinou, E. K., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11020361 · Cited by 26
Lodge, S., Lawler, N. G., Gray, N., Masuda, R., Nitschke, P., Whiley, L., Bong, S.-H., Yeap, B. B., Dwivedi, G., Spraul, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411614 · Cited by 26
Diabetes and COVID-19 risk: an miRNA perspective
Mishra, P. K., Tandon, R., & Byrareddy, S. N. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00489.2020 · Cited by 25
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
Ho, G. J., Ali, A., Takamatsu, Y., Wada, R., Masliah, E., & Hashimoto, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.013 · Cited by 24
COVID-19 alters thinking and management in metabolic diseases
le Roux, C. W. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00449-y · Cited by 23
Kishk, A., Pacheco, M. P., & Sauter, T. (2021) · iScience · doi:10.1016/j.isci.2021.103331 · Cited by 28
Situación actual de la prevención en la diabetes mellitus tipo 2
Garmendia, F. (2022) · ACTA MEDICA PERUANA · doi:10.35663/amp.2022.391.2162 · Cited by 31
Tisler, A., Stirrup, O., Pisarev, H., Kalda, R., Meister, T., Suija, K., Kolde, R., Piirsoo, M., & Uusküla, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278057 · Cited by 25
Mone, P., Jankauskas, S. S., Manzi, M. V., Gambardella, J., Coppola, A., Kansakar, U., Izzo, R., Fiorentino, G., Lombardi, A., Varzideh, F., et al. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001253 · Cited by 24
Myers, A. K., Kim, T. S., Zhu, X., Liu, Y., Qiu, M., & Pekmezaris, R. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13158 · Cited by 24
Nain, Z., BARMAN, S. K., Sheam, M. M., Syed, S. B., Samad, A., Quinn, J. M. W., Karim, M. M., Himel, M. K., Roy, R. K., Moni, M. A., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab197 · Cited by 22
Diabetes and COVID19: a bidirectional relationship
Ranjit Unnikrishnan, I., & Misra, A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00961-y · Cited by 22
Severe Diabetic Ketoacidosis After the Second Dose of mRNA-1273 COVID-19 Vaccine
Zilbermint, M. F., & Demidowich, A. P. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211043552 · Cited by 22
COVID-19 and diabetes—Two giants colliding: From pathophysiology to management
Pelle, M. C., Zaffina, I., Provenzano, M., Moirano, G., & Arturi, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.974540 · Cited by 26
Dell’Aquila, K., Lee, J., Wang, S. H., Alamuri, T. T., Jennings, R. B., Tang, H., Mahesh, S., Leong, T. J., Fleysher, R., Henninger, E. M., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15120 · Cited by 23
Liao, S., Linderholm, A., Showalter, M. R., Chen, C., Fiehn, O., & Kenyon, N. J. (2021) · Obesity Science & Practice · doi:10.1002/osp4.500 · Cited by 22
Anti-inflammatory effects of GLP-1 in patients with COVID-19
Sazgarnejad, S., Yazdanpanah, N., & Rezaei, N. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1964955 · Cited by 21
Valuing COVID-19 Morbidity Risk Reductions
Robinson, L. A., Eber, M. R., & Hammitt, J. K. (2022) · Journal of Benefit-Cost Analysis · doi:10.1017/bca.2022.11 · Cited by 21
Impact of the COVID-19 Pandemic on Children and Adolescents with New-Onset Type 1 Diabetes
Kamrath, C., Eckert, A. J., Holl, R. W., & Rosenbauer, J. (2023) · Pediatric Diabetes · doi:10.1155/2023/7660985 · Cited by 24
Bernard, H., Teijeiro, A., Perez, A. C., Perna, C., Satish, B., Novials, A., Wang, J. P., & Djouder, N. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100125 · Cited by 24
Karavanaki, K., Rodolaki, K., Soldatou, A., Karanasios, S., & Kakleas, K. (2022) · Endocrine · doi:10.1007/s12020-022-03266-7 · Cited by 20
Recent updates on COVID-19: A holistic review
Jakhmola, S., Indari, O., Kashyap, D., Varshney, N., Rani, A., Sonkar, C., Baral, B., Chatterjee, S., Das, A., Kumar, R., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05706 · Cited by 22
Lasbleiz, A., Cariou, B., Darmon, P., Soghomonian, A., Ancel, P., Boullu, S., Houssays, M., Romain, F., Lagier, J., Boucékine, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113726 · Cited by 23
“The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”
Nabeh, O. A., Matter, L. M., Khattab, M. A., & Menshawey, E. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102082 · Cited by 20
SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes
Trieu, C., Sunil, B., Ashraf, A. P., Cooper, J., Yarbrough, A. H., Pinninti, S. G., & Boppana, S. B. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100271 · Cited by 21
Long, H., Li, J., Li, R., Zhang, H., Ge, H., Zeng, H., Chen, X., Lu, Q., Jiang, W., Zeng, H., et al. (2022) · Epidemiology and Infection · doi:10.1017/s095026882200022x · Cited by 20
Koufakis, T., Dimitriadis, G., Metallidis, S., Zebekakis, P. E., & Kotsa, K. (2021) · Obesity Reviews · doi:10.1111/obr.13231 · Cited by 22
Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium
Messaaoui, A., Hajselova, L., & Tenoutasse, S. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0289 · Cited by 19
Characterizing non-critically ill COVID-19 survivors with and without in-hospital rehabilitation
Musheyev, B., Janowicz, R., Borg, L., Matarlo, M., Boyle, H., Hou, W., & Duong, T. Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-00246-1 · Cited by 20
Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19
Jin, X., Wang, Y., Xu, J., Li, Y., Cheng, F., Luo, Y., Zhou, H., Lin, S., Xiao, F., Zhang, L., et al. (2023) · Molecular Genetics and Genomics · doi:10.1007/s00438-023-02014-4 · Cited by 20
Washirasaksiri, C., Sayabovorn, N., Ariyakunaphan, P., Kositamongkol, C., Chaisathaphol, T., Sitasuwan, T., Tinmanee, R., Auesomwang, C., Nimitpunya, P., Woradetsittichai, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41523-5 · Cited by 21
Hsieh, T. Y. J., Chang, R., Yong, S., Liao, P., Hung, Y., & Wei, J. C. (2023) · Diabetes Care · doi:10.2337/dc23-0936 · Cited by 21
Konwarh, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.557377 · Cited by 22
Case Report: Insulin-Dependent Diabetes Mellitus and Diabetic Keto-Acidosis in a Child With COVID-19
Nielsen‐Saines, K., Li, E., Olivera, A. M., Martin‐Blais, R., & Bulut, Y. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.628810 · Cited by 19
Quantifying Worsened Glycemic Control During the COVID-19 Pandemic
Ledford, C. J. W., Roberts, C., Whisenant, E. B., Walters, C., Akamiro, K., Butler, J., Ali, A., & Seehusen, D. A. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.s1.200446 · Cited by 19
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Montanari, M., Canonico, B., Nordi, E., Vandini, D., Barocci, S., Benedetti, S., Carlotti, E., & Zamai, L. (2021) · Advances in Biological Regulation · doi:10.1016/j.jbior.2021.100820 · Cited by 19
Rates and characteristics of SARS‐CoV‐2 infection in persons with hepatitis C virus infection
Butt, A. A., & Peng, Y. (2020) · Liver International · doi:10.1111/liv.14681 · Cited by 18
Fisk, M., Althage, M., Moosmang, S., Greasley, P. J., Cope, A. P., Jayne, D. R. W., Galloway, J. B., Hall, F. C., Wilkinson, I. B., Ambery, P., et al. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102035 · Cited by 18
McCord, J. M., Hybertson, B. M., Cota‐Gomez, A., & Gao, B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.033 · Cited by 18
Grubišić, B., Švitek, L., Ormanac, K., Sabo, D., Mihaljević, I., Bilić-Čurčić, I., & Kolarić, T. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411576 · Cited by 20
Unveiling the Clinical Spectrum of Post-COVID-19 Conditions: Assessment and Recommended Strategies
Assiri, A. M., Alamaa, T., Elenezi, F., Alsagheir, A. I., Alzubaidi, L. M. Y., TIeyjeh, I., Alhomod, A. S., Gaffas, E. M., & Amer, S. A. (2024) · Cureus · doi:10.7759/cureus.52827 · Cited by 26
An inaugural diabetic ketoacidosis with acute pancreatitis during COVID-19
Tollard, C., Champenois, V., Delemer, B., Carsin-Vu, A., & Barraud, S. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01624-3 · Cited by 18
Yonekawa, A., & Shimono, N. (2022) · Biology · doi:10.3390/biology11030400 · Cited by 22
Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
Moon, H., Suh, S., & Park, M. K. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e12 · Cited by 17
Reges, O., Test, T., Hoshen, M., Cicurel, A., Saliba, W., Greenland, P., Dicker, D., & Lavie, G. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003052 · Cited by 18
Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
Huang, Q. M., An, R., Wang, H., Yang, Y., Tang, C., Wang, J., Yu, W., Zhou, Y., Zhang, Y., Wu, D., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2203782 · Cited by 17
Shukla, A. K., Awasthi, K., Usman, K., & Banerjee, M. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i4.606 · Cited by 21
Adewuyi, E. O., Porter, T., O’Brien, E. K., Olaniru, O. E., Verdile, G., & Laws, S. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06333-z · Cited by 18
The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons
Zollner, A., Meyer, M., Jukic, A., Adolph, T. E., & Tilg, H. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/pmie8461 · Cited by 17
Han, M. J., & Heo, J. H. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s294458 · Cited by 17
Subacute (De Quervain) thyroiditis during the COVID‐19 pandemic
Abreu, R. F., Miguel, R., & Saieg, M. A. (2021) · Cancer Cytopathology · doi:10.1002/cncy.22449 · Cited by 17
Purroy, F. F., & Arqué, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252351 · Cited by 17
Metabolic reprogramming and immune regulation in viral diseases
Ganesh, G. V., & Ramkumar, K. M. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2268 · Cited by 20
Elbarbary, N. S., Santos, T. J. D., de Beaufort, C. E., Wiltshire, E. J., Pulungan, A. B., & Scaramuzza, A. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735554 · Cited by 18
The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19
Cinti, F., & Cinti, S. (2022) · Cells · doi:10.3390/cells11132109 · Cited by 17
Loh, D., & Reiter, R. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158122 · Cited by 17
Serum metabolomic abnormalities in survivors of non-severe COVID-19
Li, F., Fu, L., Liu, X., Liu, X.-A., Liang, Y., Lv, Y., Yang, Z., Guo, A., Chen, Z., Li, W., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10473 · Cited by 20
SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
Ji, N., Zhang, M., Ren, L., Wang, Y., Hu, B., Xiang, J., Gong, Y., Wu, C., Qu, G., Ding, W., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2059400 · Cited by 19
Bhattacharyya, A., Seth, A. K., Srivast, N., Imeokparia, M., & Rai, S. N. (2021) · Research Square · doi:10.21203/rs.3.rs-144684/v1 · Cited by 22
Millette, K., Cuala, J., Wang, P., Marks, C., Woo, V., Hayun, M., Kang, H., Martín, M. G., Dhawan, S., Chao, L. C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-592374/v1 · Cited by 17
Metadata
- Authors
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
- Affiliations
- King's College London (GB)
- Monash University (AU)
- Imperial College London (GB)
- Technische Universität Dresden (DE)
- University of Colorado Anschutz (US)
- Agostino Gemelli University Polyclinic (IT)
- Nanyang Technological University (SG)
- University of Pisa, Pisa, Italy
- Peking University (CN)
- Kings Health Partners (GB)
- University of Michigan (US)
- University of Leicester (GB)
- Université de Yaoundé I (CM)
- University of Montpellier, Montpellier, France
- Corresponding author
- Rubino, Francesco
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 789-790
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7304415
- OpenAlex
- W3035586023
- Cited by
- 801
- References
- 5
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Transcampus of Technische Universität Dresden & King’s College London
- King’s College London, London, UK and Monash University, Melbourne Australia
- Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.